Leaflet VANCOMICINA MIP 500mg powder infusion solution


Indicated for: bacterial infections

Route of administration: infusion

Substance: vancomycin (glycopeptide antibiotic)

ATC: J01XA01 (Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials)

Vancomycin is an antibiotic used to treat severe bacterial infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus spp. It works by inhibiting bacterial cell wall synthesis, leading to bacterial destruction. Vancomycin is often used in complicated infections such as endocarditis, osteomyelitis, severe pneumonia, and skin and soft tissue infections.

The medication is administered intravenously for systemic infections or orally for intestinal infections such as Clostridioides difficile colitis. The dosage and duration of treatment are adjusted based on the severity of the infection and the patient's renal function.

Common side effects include injection site reactions, skin rashes, and nausea. In rare cases, severe adverse reactions such as red man syndrome, nephrotoxicity, or ototoxicity may occur.

Vancomycin is an essential antibiotic for treating severe bacterial infections, providing an effective option for patients with infections resistant to other antibiotics.

General data about VANCOMICINA MIP 500mg

  • Substance: vancomycin
  • Date of last drug list: 01-05-2026
  • Commercial code: W67244002
  • Concentration: 500mg
  • Pharmaceutical form: powder infusion solution
  • Quantity: 5
  • Product type: generic
  • Price: 243.02 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: MIP PHARMA GMBH - GERMANIA
  • Holder: MIP PHARMA GMBH - GERMANIA
  • Number: 13302/2020/02
  • Shelf life: 2 years-after packing for marketing;after reconstitution-it is used immediately

Concentrations available for vancomycin

  • 1000mg
  • 125mg
  • 1g
  • 250mg
  • 500mg

Compensation lists for VANCOMICINA MIP 500mg MIP Pharma

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

243.02 RON

170.22 RON

72.80 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

243.02 RON

170.22 RON

72.80 RON